VolitionRx Limited Total Liabilities
VolitionRx Limited (VNRX) had Total Liabilities of $41.84 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-13
- 2026-06-30: Liabilities $41.84M.
- 2026-03-31: Liabilities $42.40M.
- 2025-12-31: Liabilities $42.49M.
- 2025-09-30: Liabilities $42.40M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $41.84M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $42.40M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $42.49M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $42.40M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $41.80M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $37.55M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $35.51M 10-K · filed 2026-03-31 |
| 2024-09-30 | $35.32M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $35.97M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $36.05M 10-Q · filed 2024-05-13 |
| 2023-12-31 | $36.66M 10-K · filed 2025-03-31 |
| 2023-09-30 | $20.89M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $22.44M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $21.02M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $21.42M 10-K · filed 2024-03-25 |
| 2022-09-30 | $20.50M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $20.27M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $20.87M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $9.77M 10-K · filed 2023-03-15 |
| 2021-09-30 | $8.82M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $8.61M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $9.35M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $9.86M 10-K · filed 2022-03-30 |
| 2020-09-30 | $7.13M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $7.58M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $7.69M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $7.09M 10-K · filed 2021-03-22 |
| 2019-09-30 | $5.97M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $6.50M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $5.52M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $5.35M 10-K · filed 2020-02-20 |
| 2018-09-30 | $5.61M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $6.25M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $4.97M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $4.67M 10-K · filed 2019-03-13 |
| 2017-09-30 | $4.97M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $4.39M 10-Q · filed 2017-08-10 |
| 2017-03-31 | $4.04M 10-Q · filed 2017-05-11 |
| 2016-12-31 | $3.56M 10-K · filed 2018-03-01 |
| 2016-09-30 | $2.48M 10-Q · filed 2016-11-10 |
| 2016-06-30 | $2.03M 10-Q · filed 2016-08-11 |
| 2016-03-31 | $1.99M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.67M 10-K · filed 2017-03-10 |
| 2015-09-30 | $1.72M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $1.92M 10-Q · filed 2015-08-11 |
| 2015-03-31 | $1.28M 10-Q · filed 2015-05-12 |
| 2014-12-31 | $3.06M 10-K · filed 2016-03-11 |
| 2014-09-30 | $7.95M 10-Q · filed 2014-11-06 |
| 2014-06-30 | $3.58M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $5.63M 10-Q · filed 2014-05-15 |
| 2013-12-31 | $1.39M 10-K · filed 2015-03-18 |
| 2013-09-30 | $1.86M 10-Q · filed 2013-10-31 |
| 2013-06-30 | $1.81M 10-Q · filed 2013-07-29 |
| 2013-03-31 | $1.56M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $1.38M 10-K · filed 2014-03-28 |
| 2012-09-30 | $1.09M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $1.03M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $1.22M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $1.16M 10-K · filed 2013-04-01 |
| 2010-12-31 | $1.45M 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |